Li Lin - PharmaEngine Director
4162 Stock | TWD 92.60 1.60 1.76% |
Director
Ms. Li Chen Lin was serving as Director in PharmaEngine, Inc. since March 18, 2014. She holds a Master degree in Economics from National Taipei University, Taiwan. since 2014.
Tenure | 10 years |
Phone | 886 2 2515 8228 |
Web | https://www.pharmaengine.com |
Li Lin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Li Lin against PharmaEngine stock is an integral part of due diligence when investing in PharmaEngine. Li Lin insider activity provides valuable insight into whether PharmaEngine is net buyers or sellers over its current business cycle. Note, PharmaEngine insiders must abide by specific rules, including filing SEC forms every time they buy or sell PharmaEngine'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Li Lin over three months ago Northann Corp exotic insider transaction detected |
PharmaEngine Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Xiuming Zhuang | Medigen Biotechnology | N/A | |
Longye Zhuo | OBI Pharma | N/A | |
Tianfu Lin | TTY Biopharm Co | N/A | |
ChingChow Chen | TaiMed Biologics | N/A | |
Zijiang Yang | TTY Biopharm Co | N/A | |
Yingying Liao | TTY Biopharm Co | N/A | |
ChungMing Chang | OBI Pharma | N/A | |
Taichang Wang | OBI Pharma | N/A | |
LuPing Chow | TaiMed Biologics | N/A | |
TienFu Lin | TTY Biopharm Co | N/A | |
Jerry Fong | OBI Pharma | N/A | |
MingLing Hsueh | TTY Biopharm Co | N/A | |
Frank Chen | OBI Pharma | N/A | |
Chuan Lin | TTY Biopharm Co | N/A | |
Tamon Tseng | TaiMed Biologics | N/A | |
Quan Lin | TTY Biopharm Co | N/A | |
Ziliang Huang | Medigen Biotechnology | N/A | |
Zhaolian Huang | TaiMed Biologics | N/A | |
Ziling Zhang | Medigen Biotechnology | N/A | |
Yangzong Cai | OBI Pharma | N/A | |
Howard Lee | TaiMed Biologics | N/A |
Management Performance
Return On Equity | 0.0985 | |||
Return On Asset | 0.0589 |
PharmaEngine Leadership Team
Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiuji Zhang, Director | ||
Lin C, Director | ||
PoWu Gean, Director | ||
Changjing Ye, CEO, General Manager, Director | ||
HongRen Wang, Pres CEO | ||
Yusheng Zhao, Director | ||
LiSheng Chu, Independent Director | ||
Fuxiu Yin, Independent Director | ||
Guocai Pan, Director | ||
Yuqing Su, Independent Director | ||
ChiHsing Chang, VP Devel | ||
Kunhong Lai, Independent Director | ||
Chuan Lin, Director | ||
YuFang Hu, General Manager | ||
Bowu Jian, Director | ||
Qiying Huang, Director | ||
Jinrong Lin, Director | ||
Jeffrey Suen, Chairman of the Board | ||
Peter Wu, Director Sales | ||
Junhui He, Chairman of the Board | ||
Quan Lin, Director | ||
Zhili Wang, Independent Director | ||
C Chang, Deputy General Manager-Finance & Administration | ||
Kangji Zhou, Independent Director | ||
Hubert Chan, Deputy General Manager-Clinical & Regulatory Affairs | ||
KangChi Chou, Independent Director | ||
Melody Lin, Director HR | ||
Lizhen Lin, Director | ||
Li Lin, Director | ||
Qixing Zhang, Senior Head-Finance and Administration Management | ||
WenHwa Chang, Director | ||
Ruiwen Wu, Director | ||
Yihui Lin, Director | ||
Jose Hsieh, Sr Accounting | ||
Zhaosheng Wu, Deputy Head of Development Department | ||
FuShiow Yin, Independent Director | ||
Huai Wang, Independent Director | ||
Grace Yeh, CEO, General Manager, Director | ||
Qixiang Chen, Director | ||
MingThau Sheu, Director | ||
Xinyi Lin, Director |
PharmaEngine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0985 | |||
Return On Asset | 0.0589 | |||
Profit Margin | 0.54 % | |||
Operating Margin | 0.53 % | |||
Current Valuation | 14.42 B | |||
Shares Outstanding | 143.69 M | |||
Shares Owned By Insiders | 22.57 % | |||
Shares Owned By Institutions | 20.72 % | |||
Price To Book | 4.72 X | |||
Price To Sales | 24.13 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PharmaEngine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PharmaEngine's short interest history, or implied volatility extrapolated from PharmaEngine options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for PharmaEngine Stock analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Stocks Directory Find actively traded stocks across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |